For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nRSM6331Wa&default-theme=true
RNS Number : 6331W Puma VCT 13 PLC 13 March 2026
Puma VCT 13 plc
13 March 2026
Issue of Equity
The Directors of Puma VCT 13 plc (the "Company") are pleased to announce that
the Company has today made an allotment of 542,225 Ordinary Shares of £0.0005
each pursuant to the Company's dividend reinvestment scheme ("DRIS").
The Ordinary Shares were allotted at an issue price of £1.1763 per share
(being the most recently announced net asset value per Ordinary Share of
120.63p (unaudited) as at 31 December 2025 (as announced on 9 January 2026) as
adjusted for the dividend paid to shareholders on 13 March 2026).
Following this allotment, the total number of Ordinary Shares in issue is
190,435,907. Therefore, the total number of voting rights in the Company is
190,435,907. This figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
Application will be made for the Ordinary Shares so allotted to be admitted to
the Official List of the FCA and to trading on the London Stock Exchange's
main market for listed securities, and dealings are expected to commence on or
around 19 March 2026. Definitive documents of title are expected to be
despatched within 10 business days of allotment.
For further information please contact:
Eliot Kaye
Company Secretary
Puma VCT 13 plc
020 7408 4050
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEJJMTTMTIBBJF
Copyright 2019 Regulatory News Service, all rights reserved